+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anthrax Treatment Market - Global Forecast 2025-2030- Product Image
Anthrax Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Anthrax Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015073
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Anthrax Treatment Market is undergoing rapid evolution as health agencies, manufacturers, and innovation leaders collaborate to address persistent biological threat challenges and strengthen national resilience.

Market Snapshot: Anthrax Treatment Market Growth & Dynamics

The Anthrax Treatment Market grew from USD 415.66 million in 2024 to USD 449.92 million in 2025. It is expected to continue growing at a CAGR of 7.94%, reaching USD 657.42 million by 2030. Strong drivers include heightened global focus on health security, bioterrorism risk preparedness, and sustained government procurement programs. The market's expansion is supported by advanced therapeutic development and ongoing regulatory engagement, reflecting the sector's essential role in bioemergency response and preparedness.

Scope & Segmentation of the Anthrax Treatment Market

  • Therapeutic Modality: Antibiotic therapy (ciprofloxacin, doxycycline, penicillin), antitoxin therapy (Anthim, obiltoxaximab, raxibacumab), supportive care (intensive care treatment, respiratory support, symptomatic treatment), and vaccine therapy (anthrax vaccine adsorbed, recombinant protective antigen vaccine).
  • End User: Clinics, hospitals, public health agencies, and research institutes.
  • Distribution Channel: Government procurement, hospital pharmacies, online pharmacies, retail pharmacies.
  • Route of Administration: Intravenous administration and oral administration.
  • Regional Coverage: Americas (including U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Saudi Arabia, South Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea).
  • Technology Platforms: Monoclonal antibodies, recombinant vaccine platforms, advanced drug delivery systems, and modular manufacturing technologies.
  • Leading Companies: Emergent BioSolutions, GlaxoSmithKline, Elusys Therapeutics, Nighthawk Biosciences, and Almirall.

Key Takeaways for Decision-Makers

  • Multi-pronged anthrax treatment approaches are driving integrated strategies, combining antibiotics, antitoxin agents, and supportive care to address evolving pathogen profiles and resistance concerns.
  • Technological innovation is fueling progress in monoclonal antibody development and advanced delivery formats, enhancing patient outcomes and compliance in diverse healthcare environments.
  • Regional agility remains critical as markets adapt to distinct regulatory frameworks, infrastructure capabilities, and local threat perceptions, informing tailored procurement and deployment strategies.
  • Collaborative models involving academic centers, government agencies, and private innovators are accelerating product development, scale-up, and distribution via real-world evidence and data sharing initiatives.
  • Strategic segmentation by end user and channel supports more precise resource allocation and enhances system-level readiness during potential outbreak scenarios.

Tariff Impact on Anthrax Treatment Supply Chains

Revised United States tariff measures in 2025 have influenced procurement, manufacturing costs, and supply chain strategies across the anthrax treatment ecosystem. Domestic producers face increased input costs for pharmaceutical precursors and packaging materials, prompting sourcing diversification and long-term contract negotiation. Internationally, changes in trade policy impact the flow of antitoxin monoclonal antibodies and vaccine components, pushing companies to strengthen compliance, quality assurance protocols, and regulatory affairs functions. Health systems must rapidly adapt reimbursement and deployment strategies to maintain resilience and uninterrupted access.

Methodology & Data Sources

This analysis integrates peer-reviewed journal data, clinical trial registries, health agency reports, and expert interviews. The research applies comparative analysis, SWOT and PESTEL tools, and process mapping to evaluate internal and external market factors. All findings were validated through government procurement records and expert panel reviews to ensure accuracy and robustness.

Why This Report Matters: Anthrax Treatment Market

  • Delivers authoritative insights guiding senior leaders on technology trends, threat preparedness, and competitive dynamics in the anthrax treatment sector.
  • Enables precise resource allocation, crisis scenario planning, and strategic investments targeting supply chain stability and patient access.
  • Supports long-term policy, procurement, and partnership decisions by presenting clear segmentation, emerging regional priorities, and validated industry data.

Conclusion: Strategic Outlook for Market Leadership

The anthrax treatment market’s progression hinges on collaborative innovation, adaptive supply chains, and the ability to meet emerging global health challenges. Stakeholders equipped with timely intelligence and actionable strategies will strengthen preparedness and help safeguard public health resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in monoclonal antibody formulations for postexposure anthrax prophylaxis
5.2. Integration of rapid polymerase chain reaction diagnostics to streamline early anthrax treatment
5.3. Emergence of antibiotic resistance in Bacillus anthracis strains affecting anthrax therapy outcomes
5.4. Regulatory approval pathways for next-generation anthrax vaccines with enhanced immune response
5.5. Adoption of aerosolized antibiotic delivery systems for targeted pulmonary anthrax treatment
5.6. Clinical trial results for anthrax antitoxin combinations with standard antimicrobial regimens
5.7. Development of broad-spectrum synthetic peptides targeting multidrug-resistant anthrax infections
5.8. Government procurement and stockpiling strategies for anthrax antitoxins in biodefense readiness
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anthrax Treatment Market, by Therapeutic Modality
8.1. Introduction
8.2. Antibiotic Therapy
8.2.1. Ciprofloxacin
8.2.2. Doxycycline
8.2.3. Penicillin
8.3. Antitoxin Therapy
8.3.1. Anthim
8.3.2. Obiltoxaximab
8.3.3. Raxibacumab
8.4. Supportive Care
8.4.1. Intensive Care Treatment
8.4.2. Respiratory Support
8.4.3. Symptomatic Treatment
8.5. Vaccine Therapy
8.5.1. Anthrax Vaccine Adsorbed
8.5.2. Recombinant Protective Antigen Vaccine
9. Anthrax Treatment Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
9.4. Public Health Agencies
9.5. Research Institutes
10. Anthrax Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Government Procurement
10.3. Hospital Pharmacies
10.4. Online Pharmacies
10.5. Retail Pharmacies
11. Anthrax Treatment Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous Administration
11.3. Oral Administration
12. Americas Anthrax Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anthrax Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anthrax Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Emergent BioSolutions, Inc.
15.3.2. GlaxoSmithKline plc.
15.3.3. Elusys Therapeutics, Inc.
15.3.4. Nighthawk Biosciences, Inc.
15.3.5. Almirall, LLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTHRAX TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTHRAX TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANTHRAX TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANTHRAX TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANTHRAX TREATMENT MARKET: RESEARCHAI
FIGURE 24. ANTHRAX TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. ANTHRAX TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. ANTHRAX TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTHRAX TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTHRAX TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTHRAX TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY CIPROFLOXACIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY CIPROFLOXACIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY PENICILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTHIM, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTHIM, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY OBILTOXAXIMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY OBILTOXAXIMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RAXIBACUMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RAXIBACUMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY INTENSIVE CARE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY INTENSIVE CARE TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY SYMPTOMATIC TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY SYMPTOMATIC TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTHRAX VACCINE ADSORBED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ANTHRAX VACCINE ADSORBED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RECOMBINANT PROTECTIVE ANTIGEN VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RECOMBINANT PROTECTIVE ANTIGEN VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY PUBLIC HEALTH AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY PUBLIC HEALTH AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY GOVERNMENT PROCUREMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY GOVERNMENT PROCUREMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY INTRAVENOUS ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTHRAX TREATMENT MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ANTHRAX TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 112. CANADA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 113. CANADA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 114. CANADA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 115. CANADA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 116. CANADA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 117. CANADA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 118. CANADA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 119. CANADA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 120. CANADA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 121. CANADA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. CANADA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. CANADA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. CANADA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. ITALY ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 258. ITALY ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 259. ITALY ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 260. ITALY ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 261. ITALY ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 262. ITALY ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 263. ITALY ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 264. ITALY ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 265. ITALY ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 266. ITALY ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 267. ITALY ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. ITALY ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. ITALY ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. ITALY ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. ITALY ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. ITALY ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. SPAIN ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA ANTHRAX TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY THERAPEUTIC MODALITY, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTIBIOTIC THERAPY, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY ANTITOXIN THERAPY, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY VACCINE THERAPY, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA ANTHRAX TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD M

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Anthrax Treatment market report include:
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline plc.
  • Elusys Therapeutics, Inc.
  • Nighthawk Biosciences, Inc.
  • Almirall, LLC

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 449.92 Million
Forecasted Market Value ( USD ) by 2030 $ 657.42 Million
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Anthrax Therapeutics - Global Strategic Business Report - Product Image

Anthrax Therapeutics - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Anthrax Treatment - Global Strategic Business Report - Product Image

Anthrax Treatment - Global Strategic Business Report

  • Report
  • 373 Pages
  • Global
From
Anthrax - Pipeline Insight, 2025 - Product Image

Anthrax - Pipeline Insight, 2025

  • Clinical Trials
  • 50 Pages
  • Global
From
Anthrasil Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Anthrasil Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Hunter's Tropical Medicine and Emerging Infectious Diseases. Edition No. 10 - Product Image

Hunter's Tropical Medicine and Emerging Infectious Diseases. Edition No. 10

  • Book

About the Market

The Anthrax Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat and prevent anthrax. Anthrax is a serious bacterial infection caused by the bacterium Bacillus anthracis. It can be contracted through contact with infected animals or contaminated animal products, or through inhalation of the bacteria. Treatment of anthrax typically involves antibiotics, such as ciprofloxacin, doxycycline, and penicillin. Vaccines are also available to prevent anthrax infection. The Anthrax Drug market is highly competitive, with a number of companies offering products to treat and prevent anthrax. These include GlaxoSmithKline, Pfizer, Merck, and Sanofi. Other companies, such as Emergent BioSolutions, are also involved in the development of anthrax drugs. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.